MedCity News: Back Bay Life Science Advisors on Reproductive Health Genetic Testing Market

Back Bay Life Science Advisors Senior Vice President of Strategy Consulting, Christopher Leo, wrote a piece for MedCity News around the burgeoning reproductive health genetic testing market.

Dr. Leo explores factors priming the market to grow upwards of $1.5 billion in the coming years and adding to broader solutions for this patient population, including:

  • patient demand and desire for information in a very proactive population

  • willingness to pay out-of-pocket

  • physician desire to provide a comprehensive prenatal testing offering to their patients

  • potentially lower costs given intense competition and evolving technology.

“Charting the growth in the reproductive health genetic testing market” can be read and shared on MedCity News. 

Chris Leo Posts, NewsBack Bay Life Science AdvisorsGenetic testing, MedCity, Prenatal testing, Reproductive health